Search results for: Supply of Medicine
Filter search results
OHE’s submission to a parliamentary inquiry on UK drug shortages
6 October 2025
…reimbursement decisions. Causes of Medicine Supply Chain Issues Although the causes of drug shortages are interlinked and multifactorial, with the root cause often difficult to establish, OHE research has found three main…
The Importance of Diversity of Supply in Rare Diseases Markets
23 January 2025
…Supplier diversity improves supply and healthcare system resilience, helping to mitigate the impact of medicine shortages. Other innovators supplying in the same market could help cover a shortfall in production…
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
…the health system (or supply-side CET). The OHE authors’ general framework brings together a bargaining process with elements of the demand and supply side of the pharmaceutical markets. The key result…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…governments – in delivering six vaccines approved by stringent regulatory authorities within one year of the publication of the genome of the virus, together with the tripling of total global…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…make some of their contracted supply available to the COVAX AMC, although some of this replaces earlier commitments. Practical proposals to increase manufacturing capacity and vaccine supply within a voluntary…
The Cost of Drug Shortages
16 September 2024
…been observed across a range of therapeutic areas, particularly in the off-patent generic and biosimilar markets. Optimal policy design and decision-making require an understanding of the root causes of drug…
Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds
3 March 2020
…Group. Novel elements of the model include the incorporation of bargaining and Research & Development (R&D) costs to link pharmaceutical pricing and social surplus (the sum of health gains and…
Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic
21 April 2021
…candidates and the risk of real-world safety concerns about one particular vaccine to disrupt the supply critically. Diversification of types within each tier might prevent delays stemming from vaccines of…
The State of Play for Cost-effectiveness Thresholds
28 June 2022
In a new paper led by OHE, an international team of co-authors considers the evidence for supply-side cost-effectiveness thresholds, providing a set of recommendations for policymakers. In this blog post,…